BHARAT PARENTERALS
|
BHARAT PARENTERALS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -18.32 | 24.94 | 28.40 | 36.46 | 35.59 |
| CEPS(Rs) | -12.12 | 33.57 | 37.40 | 47.57 | 45.98 |
| DPS(Rs) | 1.00 | 1.00 | 0.75 | - | - |
| Book NAV/Share(Rs) | 479.79 | 338.96 | 315.63 | 287.16 | 250.34 |
| Tax Rate(%) | -28.64 | 43.84 | 33.26 | 25.34 | 25.10 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 0.79 | 10.32 | 9.17 | 11.58 | 10.67 |
| EBIT Margin(%) | -6.15 | 8.68 | 11.99 | 12.11 | 11.79 |
| Pre Tax Margin(%) | -9.95 | 7.14 | 10.80 | 11.57 | 11.47 |
| PAT Margin (%) | -12.80 | 4.01 | 7.21 | 8.64 | 8.59 |
| Cash Profit Margin (%) | -2.45 | 7.45 | 9.91 | 11.40 | 11.14 |
| Performance Ratios | |||||
| ROA(%) | -7.52 | 2.46 | 5.45 | 9.80 | 10.52 |
| ROE(%) | -16.55 | 5.54 | 9.03 | 13.46 | 15.53 |
| ROCE(%) | -4.85 | 7.74 | 12.57 | 17.18 | 20.24 |
| Asset Turnover(x) | 0.59 | 0.61 | 0.76 | 1.13 | 1.23 |
| Sales/Fixed Asset(x) | 1.18 | 1.56 | 2.85 | 3.35 | 3.80 |
| Working Capital/Sales(x) | 2.51 | 3.63 | 3.38 | 2.36 | 2.27 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.85 | 0.64 | 0.35 | 0.30 | 0.26 |
| Receivable days | 167.45 | 176.78 | 155.57 | 106.98 | 113.54 |
| Inventory Days | 71.34 | 69.16 | 49.06 | 32.72 | 39.53 |
| Payable days | 131.49 | 127.69 | 99.70 | 66.97 | 93.48 |
| Valuation Parameters | |||||
| PER(x) | - | 44.99 | 11.83 | 9.36 | 9.42 |
| PCE(x) | -81.47 | 33.43 | 8.98 | 7.18 | 7.29 |
| Price/Book(x) | 2.06 | 3.31 | 1.06 | 1.19 | 1.34 |
| Yield(%) | 0.10 | 0.09 | 0.22 | - | - |
| EV/Net Sales(x) | 2.36 | 3.05 | 1.07 | 0.99 | 0.99 |
| EV/Core EBITDA(x) | 56.08 | 25.07 | 7.30 | 5.86 | 5.95 |
| EV/EBIT(x) | -38.24 | 35.01 | 8.94 | 7.20 | 7.24 |
| EV/CE(x) | 1.57 | 2.24 | 1.01 | 0.93 | 1.02 |
| M Cap / Sales | 2.00 | 2.50 | 0.89 | 0.93 | 0.94 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 30.31 | 19.83 | 2.81 | 3.60 | -10.31 |
| Core EBITDA Growth(%) | -54.91 | -0.83 | -10.65 | 5.67 | -14.22 |
| EBIT Growth(%) | -192.36 | -13.03 | -10.42 | 4.63 | -17.14 |
| PAT Growth(%) | -515.39 | -33.09 | -24.49 | 2.44 | -15.85 |
| EPS Growth(%) | -173.44 | -12.16 | -22.11 | 2.45 | -15.55 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.55 | 0.80 | 0.27 | 0.11 | 0.09 |
| Current Ratio(x) | 1.59 | 1.38 | 1.54 | 3.46 | 3.39 |
| Quick Ratio(x) | 1.28 | 1.06 | 1.22 | 2.96 | 2.88 |
| Interest Cover(x) | -1.62 | 5.66 | 10.07 | 22.35 | 36.44 |
| Total Debt/Mcap(x) | 0.26 | 0.24 | 0.26 | 0.09 | 0.06 |
Compare Financial Ratios of peers of BHARAT PARENTERALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BHARAT PARENTERALS | ₹936.6 Cr | -4% | 2.4% | -0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
BHARAT PARENTERALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BHARAT PARENTERALS | -4% |
2.4% |
-0.2% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses
